Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Jie Yu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Oncology Reports|October 6, 2011
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancerYi Guo, Pingfu Fu, Honglan Zhu, et al.
Huan Jing Ke Xue= Huanjing Kexue|May 16, 2019
[Effects of Long-term Poly-P Deficiency on the Metabolic Properties of <i>Accumulibacter</i> in AO-SBR System]Shao-Po Wang, Zhu Li, Le-Dan Zhao, et al.
International Journal of Oncology|April 6, 2006
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivoYongping You, Peiyu Pu, Qiang Huang, et al.
Huan Jing Ke Xue= Huanjing Kexue|December 25, 2024
[Progress in the Application of Biochar in Constructed Wetland]Shao-Po Wang, Long-Xiao Bai, Ling-Jie Liu, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2014
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancerIslam R Younis, Daniel J George, Terence J McManus, et al.
Anticancer Research|February 27, 2022
First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case ReportMohamad W Salkini, Xuqing Yang, Fayyaz Haider Hashmi, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Translational Oncology|August 7, 2010
A Polymorphic Variant of AFAP-110 Enhances cSrc ActivityDavid A Clump, Jing Jie Yu, Youngjin Cho, et al.
Anticancer Research|August 2, 2019
Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and CarboplatinJing Jie Yu, Thomas Hogan, Chad Morley, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncology Reports|October 6, 2011
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancerYi Guo, Pingfu Fu, Honglan Zhu, et al.
Huan Jing Ke Xue= Huanjing Kexue|May 16, 2019
[Effects of Long-term Poly-P Deficiency on the Metabolic Properties of <i>Accumulibacter</i> in AO-SBR System]Shao-Po Wang, Zhu Li, Le-Dan Zhao, et al.
International Journal of Oncology|April 6, 2006
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivoYongping You, Peiyu Pu, Qiang Huang, et al.
Huan Jing Ke Xue= Huanjing Kexue|December 25, 2024
[Progress in the Application of Biochar in Constructed Wetland]Shao-Po Wang, Long-Xiao Bai, Ling-Jie Liu, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2014
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancerIslam R Younis, Daniel J George, Terence J McManus, et al.
Anticancer Research|February 27, 2022
First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case ReportMohamad W Salkini, Xuqing Yang, Fayyaz Haider Hashmi, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Translational Oncology|August 7, 2010
A Polymorphic Variant of AFAP-110 Enhances cSrc ActivityDavid A Clump, Jing Jie Yu, Youngjin Cho, et al.
Anticancer Research|August 2, 2019
Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and CarboplatinJing Jie Yu, Thomas Hogan, Chad Morley, et al.
Pageof 3